AXSM - Axsome Therapeutics Inc
IEX Last Trade
88.73
-0.380 -0.428%
Share volume: 311,826
Last Updated: Fri 30 Aug 2024 10:00:00 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$89.11
-0.38
-0.43%
Summary score
29%
Profitability
25%
Dept financing
19%
Liquidity
75%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-75.75%
Return on assets
-17.31%
Return on sales
-168.03%
Return on invested capital
143.23%
Total debt ratio
59.2%
Debt ratio change over timeo
-0.76%
Current Ratio
4.99%
Quick Ratio
4.72%
Cash Position Ratio
4.64%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-36.57%
Return on assets
-10.49%
Return on sales
-100.68%
Return on invested capital
207.76%
Total debt ratio
62.68%
Debt ratio change over timeo
-0.58%
Current Ratio
3.95%
Quick Ratio
3.86%
Cash Position Ratio
3.13%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
-47.46%
Return on assets
-12.59%
Return on sales
-91.58%
Return on invested capital
116.23%
Total debt ratio
73.61%
Debt ratio change over time
-0.59%
Current Ratio
3.2%
Quick Ratio
3.09%
Cash Position Ratio
2.3%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-104.66%
Return on assets
-106%
Return on sales
-147.04%
Return on invested capital
20.76%
Total debt ratio
-75.55%
Debt ratio change over time
-0.76%
Current Ratio
1.83%
Quick Ratio
1.56%
Cash Position Ratio
1.66%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AXSM | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -75.75% | 18.83% | 17.34% | 7.6% |
| Return on assets | -17.31% | 4.16% | 8.21% | 3.22% |
| Return on sales | -168.03% | 28.21% | 41.18% | 25.37% |
| Return on invested capital | 143.23% | 9.79% | -219.55% | 7.46% |
| Profitability | 25% | 57% | 73% | 37% |
| Total debt ratio | 59.2% | 82.89% | 55.88% | 60.02% |
| Debt ratio change over time | -0.76% | -4.38% | -0.73% | -33.74% |
| Dept financing | 18% | 25% | 42% | 18% |
| Current Ratio | 3.95% | 1.12% | 0% | 1.16% |
| Quick Ratio | 3.86% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 3.13% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 12% | 12% | 15% |
| Short-term ratios | AXSM | LLY | NVO | JNJ |
|---|---|---|---|---|
| Return on equity | -36.57% | 13.31% | 0% | 13.48% |
| Return on assets | -10.49% | 4.72% | 0% | 3.05% |
| Return on sales | -100.68% | 31.4% | 0% | 25.56% |
| Return on invested capital | 207.76% | 10.68% | 0% | 13.96% |
| Profitability | 25% | 76% | 0% | 63% |
| Total debt ratio | 62.68% | 80.89% | 0% | 59.04% |
| Debt ratio change over time | -0.58% | -41.82% | 0% | 7.13% |
| Dept financing | 19% | 25% | 0% | 43% |
| Current Ratio | 3.95% | 1.12% | 0% | 1.16% |
| Quick Ratio | 3.86% | 0.86% | 0% | 0.92% |
| Cash Position Ratio | 3.13% | 0.13% | 0% | 0.52% |
| Liquididy | 75% | 14% | 0% | 17% |